Novo Holdings A/S 13D and 13G filings for LAVA Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-07 7:09 pm Sale |
2024-03-05 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 0 0.000% |
-1,878,194 (Position Closed) |
Filing |
| 2023-11-09 4:37 pm Sale |
2023-11-03 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 1,878,194 7.100% |
-521,806 (-21.74%) |
Filing |
| 2023-06-05 8:18 pm Sale |
2023-06-05 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 2,400,000 9.130% |
-670,558 (-21.84%) |
Filing |
| 2023-02-24 4:38 pm Sale |
2023-02-22 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,070,558 11.700% |
-256,754 (-7.72%) |
Filing |
| 2022-10-03 4:15 pm Unchanged |
2022-09-27 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 12.900% |
0 (Unchanged) |
Filing |
| 2022-09-30 4:45 pm Unchanged |
2022-04-21 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 8.600% |
0 (Unchanged) |
Filing |
| 2021-03-31 4:33 pm Purchase |
2021-03-24 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 13.100% |
3,327,312 (New Position) |
Filing |